Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01602237
Other study ID # 2011/2449
Secondary ID
Status Completed
Phase N/A
First received March 5, 2012
Last updated August 11, 2017
Start date February 2012
Est. completion date December 2015

Study information

Verified date August 2017
Source Haukeland University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is a follow-up of investigations done in the years 1999-2002 in bakery employees. The main purposes are to look at the associations between flour dust exposure and respiratory disease, and to find out the best ways to reduce the flour dust levels in the working environment.


Description:

Background and Methods:

Supported by the The Confederation of Norwegian Enterprise (CNBI) Working Environment Fund a follow-up study of 184 bakery workers in 5 bakeries was done in 2012, appr. 10 years after a similar study in 1999-2002. In addition a cross-sectional study in 2 other bakeries (one 'bread-factory', and a traditional bakery with three small bake shops) was added.

Altogether 253 participants, among them 61 former bakery workers, were investigated with use of questionnaires, allergy-testing (skin prick testing, and blood samples for specific IgE and total IgE), spirometry with reversibility testing, exhaled NO-measurement, and nasal measurements.

As in 1999-2002 an extensive exposure assessment was performed including personal samples of total dust (Gelman), inhalable dust (PAS6), as well as direct reading measurements of dust (Dust Track). A Job Exposure Matrix (JEM) was created enabling each participant to be assigned an exposure value of probable mean daily flour-dust exposure based on work-tasks and bakery.

Aim of study:

- Follow-up of the participants in the 1999-2002 study, both still active bakery workers and former workers, on health-status focusing on respiratory disease, sensitization to common and occupational allergens, level of sick-leave and reasons for quitting as a baker.

- Inclusion of 'new' bakery workers into the cohort as a cross-sectional study, and to compare health-status in two cross-sectional cohorts.

- To assess personal exposure to flour-dust among workers in 7 bakeries, as part of the cross-sectional study described above.

- To identify implemented flour-dust exposure reduction measures in bakeries participating in 1999-2002, and to assess the potential impact of these measures on the exposure to flour dust.


Recruitment information / eligibility

Status Completed
Enrollment 253
Est. completion date December 2015
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Employed in a bakery for more than 6 months

- and/or participant of the investigations done in 1999-2002 in 6 bakeries

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Norway Dept. of Occupational Medicine, Haukeland University Hospital Bergen

Sponsors (1)

Lead Sponsor Collaborator
Haukeland University Hospital

Country where clinical trial is conducted

Norway, 

References & Publications (4)

Kirkeleit J, Hollund BE, Riise T, Eduard W, Bråtveit M, Storaas T. Bakers' exposure to flour dust. J Occup Environ Hyg. 2017 Feb;14(2):81-91. — View Citation

Storaas T, Ardal L, Van Do T, Florvaag E, Steinsvåg SK, Irgens A, Aasen TB, Greiff L. Nasal indices of eosinophilic and exudative inflammation in bakery-workers. Clin Physiol Funct Imaging. 2007 Jan;27(1):23-9. — View Citation

Storaas T, Irgens A, Florvaag E, Steinsvåg SK, Ardal L, Do TV, Greiff L, Aasen TB. Bronchial responsiveness in bakery workers: relation to airway symptoms, IgE sensitization, nasal indices of inflammation, flour dust exposure and smoking. Clin Physiol Funct Imaging. 2007 Sep;27(5):327-34. — View Citation

Storaas T, Steinsvåg SK, Florvaag E, Irgens A, Aasen TB. Occupational rhinitis: diagnostic criteria, relation to lower airway symptoms and IgE sensitization in bakery workers. Acta Otolaryngol. 2005 Nov;125(11):1211-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Forced Exhaled Volume in one second (FEV1) The decline in FEV1 from 1999-2002 to 2012. Change/decline from 1999-2002 to 2012
Secondary Forced Vital Capacity (FVC) Before and after salbutamol-inhalation. Post-bronchodilatory measurements of FEV1 and FVC to measure the prevalence of chronic obstructive lung disease in a cohort of bakery workers Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
Secondary Inflammation markers in nasal lavage Measurement in nasal lavage of inflammation markers (albumin, tryptase, eosinophilic cationic protein) when at work (field study) Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
Secondary Specific IgE In serum measurement of specific IgE to common airborne allergens, and allergens mainly found in bakeries Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
Secondary Skin reaction to prick testing with allergen extracts Skin prick test with commercially available allergen extracts (common and occupational allergens in bakeries) Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
See also
  Status Clinical Trial Phase
Completed NCT02340130 - Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma Phase 2
Completed NCT02360072 - Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
Completed NCT01118312 - Study of Asthma and Nasal Steroids Phase 4
Completed NCT00762567 - Phenylephrine Pediatric Pharmacokinetic Study Phase 1
Completed NCT00541255 - A Long-Term Examination of Asthma From Childhood Through Adolescence
Completed NCT00279916 - Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays Phase 3
Completed NCT00963573 - Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) Phase 4
Completed NCT00524836 - Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis Phase 3
Completed NCT00521131 - Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites Phase 4
Completed NCT04132570 - A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution Phase 4
Completed NCT02784262 - Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis Phase 2
Completed NCT02596321 - A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma Phase 3
Terminated NCT02630472 - Topical Irrigation Therapy for CRS Phase 1/Phase 2
Completed NCT02279706 - Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test N/A
Completed NCT01971086 - Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary N/A
Completed NCT01771120 - Control and Burden of Asthma and Rhinitis N/A
Withdrawn NCT01177852 - Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis Phase 3
Completed NCT01469234 - A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) Phase 4
Completed NCT02879929 - Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction N/A
Completed NCT00724698 - Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria

External Links